Order Article Reprints

Nogales-Altozano P, Gómez-Marcos L, Carlón AB, Louloudes-Lázaro A, Rivera-Rodríguez A, Larraga J, Alcolea PJ, Alonso A, Larraga V, Martín V, et al. Heterologous DNA–Adenovirus Prime–Boost Strategy Expressing Bluetongue Virus VP2 and VP7 Proteins Protects Against Virulent Challenge. Vaccines. 2025; 13(9):991. https://doi.org/10.3390/vaccines13090991

Nogales-Altozano, Pablo, Laro Gómez-Marcos, Ana Belén Carlón, Andrés Louloudes-Lázaro, Alicia Rivera-Rodríguez, Jaime Larraga, Pedro J. Alcolea, Ana Alonso, Vicente Larraga, Verónica Martín, and et al. 2025. "Heterologous DNA–Adenovirus Prime–Boost Strategy Expressing Bluetongue Virus VP2 and VP7 Proteins Protects Against Virulent Challenge" Vaccines 13, no. 9: 991. https://doi.org/10.3390/vaccines13090991

Nogales-Altozano, P., Gómez-Marcos, L., Carlón, A. B., Louloudes-Lázaro, A., Rivera-Rodríguez, A., Larraga, J., Alcolea, P. J., Alonso, A., Larraga, V., Martín, V., Rojas, J. M., & Sevilla, N. (2025). Heterologous DNA–Adenovirus Prime–Boost Strategy Expressing Bluetongue Virus VP2 and VP7 Proteins Protects Against Virulent Challenge. Vaccines, 13(9), 991. https://doi.org/10.3390/vaccines13090991